Herbert T Nagasawa

USPTO Granted Patents = 12 (Patent Applications = 6)

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 57(Granted Patents)

Location History:

Richfield, MN (US) (1988 - 2015)
Irvine, CA (US) (2013 - 2015)
Minneapolis, MN (US) (2017)

Company Filing History:

7 out of 2,310

University of Minnesota

patents

4 out of 4

Max International, LLC

patents

2 out of 896

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 1988-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098118 - Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction (2024-09-24),

2. 9757354 - Therapeutic formulations and methods (2017-09-12),

3. 9173917 - Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug (2015-11-03),

4. 9144570 - Method to enhance delivery of glutathione and ATP levels in cells (2015-09-29),

5. 8853170 - Compositions comprising sugar-cysteine products (2014-10-07),

6. 8501700 - Method to enhance delivery of glutathione and ATP levels in cells (2013-08-06),

7. 6686336 - N-terminal D(-)-penicillamine peptides as aldehyde sequestration agents (2004-02-03),

8. 5624955 - Compounds that enhance the concentration of glutathione in tissues (1997-04-29),

9. 4940816 - Acylated cyanamide compounds (1990-07-10),

10. 4870056 - Acylated cyanamide composition (1989-09-26),

11. 4868114 - Method for elevating glutathione levels (1989-09-19),

12. 4726941 - Acylated cyanamide composition for treating ethanol ingestion (1988-02-23),

Title: Herbert T Nagasawa: Innovator in Pain Management and Therapeutic Formulations

Introduction

Herbert T Nagasawa is a prominent inventor based in Irvine, CA, known for his significant contributions to the fields of pain management and therapeutic formulations. With a total of 12 patents to his name, Nagasawa has made remarkable strides in developing innovative solutions for chronic pain and opioid addiction.

Latest Patents

Nagasawa's latest patents include groundbreaking work on analgesic and anti-addictive compositions aimed at treating chronic pain and opioid addiction. This invention provides a compound of formula I, along with its stereoisomers, tautomers, or pharmaceutically acceptable salts. The patent details pharmaceutical compositions and medicaments that incorporate these compounds, as well as methods for using them as therapeutic agents for pain-related disorders. Another notable patent focuses on therapeutic formulations and methods for treating cyanide poisoning, showcasing his versatility in addressing various medical challenges.

Career Highlights

Throughout his career, Nagasawa has worked with esteemed institutions such as the University of Minnesota and Max International, LLC. His work in these organizations has allowed him to collaborate with other experts in the field and further his research in innovative therapeutic solutions.

Collaborations

Nagasawa has collaborated with notable colleagues, including Chul-Hoon Kwon and Jonathan F Cohen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Herbert T Nagasawa's contributions to the fields of pain management and therapeutic formulations highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the medical community positively, paving the way for future advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.